Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Stereotactic Radiosurgery and Pembrolizumab for Recurrent Meningioma
NCT04659811Phase 2Active, not recruiting
- Start
- Mar 2021
- Primary completion
- Mar 2027
- Modality
- Immune Checkpoint Inhibitors, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of pembrolizumab in meningioma. Started Mar 2021; status: active, not recruiting.
02
Drugs
03
Conditions
meningioma
Beyond the preview
Go deeper on NCT04659811.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04659811.